Jiaotai pill (交泰丸) enhances insulin signaling through phosphatidylinositol 3-kinase pathway in skeletal muscle of diabetic rats
Authors:
- 24 August 2013
- journal article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 19 (9) , 668-674
Abstract
To investigate the effect of Jiaotai Pill (交泰丸, JTP) at different constitutional proportions on insulin signaling through phosphatidylinositol 3-kinase (PI3K) pathway in the skeletal muscle of diabetic rats. The rat model of type 2 diabetes mellitus (T2DM) was established by intravenous injection of a small dose of streptozotoein plus high fat diet feeding. JTP at the same dosage of cinnamon and the increasing dosage of Coptis chinensis was administered to diabetic rats for nine weeks respectively. Plasma glucose and insulin levels were assayed. The expressions of proteins were determined by Western blot method. All the three formulations of JTP decreased plasma glucose and fasting insulin levels as well as increased the protein expressions of insulin receptor β (InsRβ) subunit, insulin receptor substrate-1 (IRS-1), PI3K p85 subunit and glucose transporter 4 (GLUT4) in skeletal muscle. Meanwhile, JTP increased the tyrosine phosphorylation of InsRβ subunit and IRS-1, and reduced the serine phosphorylation of IRS-1 in skeletal muscle. Interestingly, the effect of JTP on improving insulin sensitivity was not dose-dependent. In contrast, JTP containing the least amount of Coptis chinensis exhibited the best effect. JTP at different constitutional proportions attenuates the development of diabetes in a rat model of T2DM. The mechanism might be associated with enhancing insulin signaling through PI3K pathway in the skeletal muscle.Keywords
This publication has 38 references indexed in Scilit:
- Prevalence of Diabetes among Men and Women in ChinaNew England Journal of Medicine, 2010
- Skeletal Muscle Insulin Resistance in Endocrine DiseaseJournal of Biomedicine and Biotechnology, 2010
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes MellitusThe Journal of Clinical Endocrinology & Metabolism, 2010
- Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 DiabetesDiabetes Care, 2009
- Thiazolidinedione use and the risk of fracturesCanadian Medical Association Journal, 2009
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid BerberineThe Journal of Clinical Endocrinology & Metabolism, 2008
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- Coptidis rhizoma extract protects against cytokine-induced death of pancreatic β-cells through suppression of NF-κ B activationExperimental & Molecular Medicine, 2007
- Protective effect of Coptidis Rhizoma on S-nitroso-N-acetylpenicillamine (SNAP)-induced apoptosis and necrosis in pancreatic RINm5F cellsLife Sciences, 2005
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001